Literature DB >> 16954600

Distribution of NPY Y5-like immunoreactivity in the rat brain.

S Michelle Morin1, Donald R Gehlert.   

Abstract

The pharmacology and brain mRNA distribution of the neuropeptide Y (NPY) rat Y5 (rY5) receptor has led to the hypothesis that this receptor might mediate the hypothalamic feeding response to NPY in addition to many other physiologic functions. However, through the use of autoradiographic techniques, only very low levels of Y5-like immunoreactive (Y5-ir) binding are detected in the rat brain. To localize the Y5 protein in the rat brain, polyclonal antibodies were raised to the carboxyl terminus of the rY5 receptor. The resulting antisera were affinity purified and characterized by specific binding to HEK293 cells that had been stably transfected with the rY5 receptor. Utilizing immunohistochemical techniques, we found a discrete pattern of Y5-ir in the rat brain. In initial studies, very low levels of Y5-ir were detected, and TSA amplification was required to visualize the staining. Areas with the highest levels of expression include the piriform cortex, supraoptic nucleus, and hippocampus. Areas with moderate levels of expression include the lateral septum, amygdala, arcuate nucleus, paraventricular hypothalamic nucleus, locus coeruleus, and cerebellum. With several exceptions, this pattern of distribution is consistent with earlier reports of rY5 mRNA and receptor protein expression.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16954600     DOI: 10.1385/JMN:29:2:109

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  28 in total

Review 1.  Central nervous system control of food intake.

Authors:  M W Schwartz; S C Woods; D Porte; R J Seeley; D G Baskin
Journal:  Nature       Date:  2000-04-06       Impact factor: 49.962

2.  Regional distribution of Y-receptor subtype mRNAs in rat brain.

Authors:  R M Parker; H Herzog
Journal:  Eur J Neurosci       Date:  1999-04       Impact factor: 3.386

3.  Functional autoradiography of neuropeptide Y Y1 and Y2 receptor subtypes in rat brain using agonist stimulated [35S]GTPgammaS binding.

Authors:  Janice L Shaw; Susan L Gackenheimer; Donald R Gehlert
Journal:  J Chem Neuroanat       Date:  2003-11       Impact factor: 3.052

4.  Molecular genetic analysis of a human neuropeptide Y receptor. The human homolog of the murine "Y5" receptor may be a pseudogene.

Authors:  P M Rose; J S Lynch; S T Frazier; S M Fisher; W Chung; P Battaglino; Z Fathi; R Leibel; P Fernandes
Journal:  J Biol Chem       Date:  1997-02-07       Impact factor: 5.157

5.  Neuropeptide Y Y(5) receptor antagonist CGP71683A: the effects on food intake and anxiety-related behavior in the rat.

Authors:  A Kask; E Vasar; L T Heidmets; L Allikmets; J E Wikberg
Journal:  Eur J Pharmacol       Date:  2001-03-02       Impact factor: 4.432

6.  Role of the Y5 neuropeptide Y receptor in limbic seizures.

Authors:  D J Marsh; S C Baraban; G Hollopeter; R D Palmiter
Journal:  Proc Natl Acad Sci U S A       Date:  1999-11-09       Impact factor: 11.205

7.  Neuropeptide Y Y5 receptors suppress in vitro spontaneous epileptiform bursting in the rat hippocampus.

Authors:  Avtandil Nanobashvili; David P D Woldbye; Henriette Husum; Tom G Bolwig; Merab Kokaia
Journal:  Neuroreport       Date:  2004-02-09       Impact factor: 1.837

8.  Species differences in the expression and distribution of the neuropeptide Y Y1, Y2, Y4, and Y5 receptors in rodents, guinea pig, and primates brains.

Authors:  Y Dumont; D Jacques; P Bouchard; R Quirion
Journal:  J Comp Neurol       Date:  1998-12-21       Impact factor: 3.215

9.  Neuropeptide Y and human pancreatic polypeptide stimulate feeding behavior in rats.

Authors:  J T Clark; P S Kalra; W R Crowley; S P Kalra
Journal:  Endocrinology       Date:  1984-07       Impact factor: 4.736

10.  Characterization of the neuropeptide Y5 receptor in the human hypothalamus: a lack of correlation between Y5 mRNA levels and binding sites.

Authors:  M A Statnick; D A Schober; S Gackenheimer; D Johnson; L Beavers; N G Mayne; J P Burnett; R Gadski; D R Gehlert
Journal:  Brain Res       Date:  1998-11-09       Impact factor: 3.252

View more
  7 in total

1.  Neuropeptide Y Y5 receptor antagonism attenuates cocaine-induced effects in mice.

Authors:  Gunnar Sørensen; Morten Jensen; Pia Weikop; Ditte Dencker; Søren H Christiansen; Claus Juul Loland; Cecilie Hee Bengtsen; Jørgen Holm Petersen; Anders Fink-Jensen; Gitta Wörtwein; David P D Woldbye
Journal:  Psychopharmacology (Berl)       Date:  2012-02-25       Impact factor: 4.530

Review 2.  Central regulation of hypothalamic-pituitary-thyroid axis under physiological and pathophysiological conditions.

Authors:  Csaba Fekete; Ronald M Lechan
Journal:  Endocr Rev       Date:  2013-12-13       Impact factor: 19.871

3.  A role for neuropeptide Y Y5 but not the Y1-receptor subtype in food deprivation-induced reinstatement of heroin seeking in the rat.

Authors:  Tia Maric; Firas Sedki; Danielle Chafetz; Nick Schoela; Uri Shalev
Journal:  Psychopharmacology (Berl)       Date:  2011-06-01       Impact factor: 4.530

4.  Activation of NPY type 5 receptors induces a long-lasting increase in spontaneous GABA release from cerebellar inhibitory interneurons.

Authors:  C J Dubois; P Ramamoorthy; M D Whim; S J Liu
Journal:  J Neurophysiol       Date:  2011-12-21       Impact factor: 2.714

5.  Cell-specific expression of neuropeptide Y Y1 receptor immunoreactivity in the rat basolateral amygdala.

Authors:  Amanda B Rostkowski; Tara L Teppen; Daniel A Peterson; Janice H Urban
Journal:  J Comp Neurol       Date:  2009-11-10       Impact factor: 3.215

6.  The identification of neuropeptide Y receptor subtype involved in phenylpropanolamine-induced increase in oxidative stress and appetite suppression.

Authors:  Yih-Shou Hsieh; Meng-Hsien Kuo; Pei-Ni Chen; Dong-Yih Kuo
Journal:  Neuromolecular Med       Date:  2012-11-20       Impact factor: 3.843

7.  Enhanced inhibitory control by neuropeptide Y Y5 receptor blockade in rats.

Authors:  A Bari; A Dec; A W Lee; J Lee; D Song; E Dale; J Peterson; S Zorn; X Huang; B Campbell; T W Robbins; A R West
Journal:  Psychopharmacology (Berl)       Date:  2014-09-07       Impact factor: 4.530

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.